WO2002066643A3 - Proteins, polynucleotides encoding them and methods of using the same - Google Patents

Proteins, polynucleotides encoding them and methods of using the same Download PDF

Info

Publication number
WO2002066643A3
WO2002066643A3 PCT/US2001/048732 US0148732W WO02066643A3 WO 2002066643 A3 WO2002066643 A3 WO 2002066643A3 US 0148732 W US0148732 W US 0148732W WO 02066643 A3 WO02066643 A3 WO 02066643A3
Authority
WO
WIPO (PCT)
Prior art keywords
proteins
methods
same
polynucleotides encoding
disclosed
Prior art date
Application number
PCT/US2001/048732
Other languages
French (fr)
Other versions
WO2002066643A2 (en
Inventor
Uriel M Malyankar
Suresh G Shenoy
Kimberly A Spytek
Bryan D Zerhusen
Meera Patturajan
Xiaojia Guo
Ramesh Kekuda
Esha A Gangolli
Richard A Shimkets
Raymond J Taupier Jr
Li Li
Muralidhara Padigaru
Original Assignee
Curagen Corp
Uriel M Malyankar
Suresh G Shenoy
Kimberly A Spytek
Bryan D Zerhusen
Meera Patturajan
Xiaojia Guo
Ramesh Kekuda
Esha A Gangolli
Richard A Shimkets
Raymond J Taupier Jr
Li Li
Muralidhara Padigaru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Curagen Corp, Uriel M Malyankar, Suresh G Shenoy, Kimberly A Spytek, Bryan D Zerhusen, Meera Patturajan, Xiaojia Guo, Ramesh Kekuda, Esha A Gangolli, Richard A Shimkets, Raymond J Taupier Jr, Li Li, Muralidhara Padigaru filed Critical Curagen Corp
Publication of WO2002066643A2 publication Critical patent/WO2002066643A2/en
Publication of WO2002066643A3 publication Critical patent/WO2002066643A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2462—Lysozyme (3.2.1.17)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants

Abstract

Disclosed herein are nucleic acid sequences that encode novel polypeptides. Also disclosed are polypeptides encoded by these nucleic acid sequences, and antibodies, which immunospecifically-bind to the polypeptide, as well as derivatives, variants, mutants, or fragments of the aforementioned polypeptide, polynucleotide, or antibody. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins.
PCT/US2001/048732 2000-11-13 2001-11-13 Proteins, polynucleotides encoding them and methods of using the same WO2002066643A2 (en)

Applications Claiming Priority (15)

Application Number Priority Date Filing Date Title
US60/248,153 2000-11-13
US24959800P 2000-11-17 2000-11-17
US60/249,598 2000-11-17
US26424001P 2001-01-26 2001-01-26
US60/264,240 2001-01-26
US26612701P 2001-02-02 2001-02-02
US60/266,127 2001-02-02
US26956201P 2001-02-16 2001-02-16
US60/269,562 2001-02-16
US30434801P 2001-07-10 2001-07-10
US60/304,348 2001-07-10
US30926101P 2001-07-31 2001-07-31
US60/309,261 2001-07-31
US31328301P 2001-08-17 2001-08-17
US60/313,283 2001-08-17

Publications (2)

Publication Number Publication Date
WO2002066643A2 WO2002066643A2 (en) 2002-08-29
WO2002066643A3 true WO2002066643A3 (en) 2003-06-26

Family

ID=27569466

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/048732 WO2002066643A2 (en) 2000-11-13 2001-11-13 Proteins, polynucleotides encoding them and methods of using the same

Country Status (1)

Country Link
WO (1) WO2002066643A2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8958881B2 (en) 2005-08-19 2015-02-17 Brainsgate Ltd. Neuroprotective electrical stimulation
US9233245B2 (en) 2004-02-20 2016-01-12 Brainsgate Ltd. SPG stimulation

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002250143A1 (en) * 2001-03-16 2002-10-03 Eli Lilly And Company Lp mammalian proteins; related reagents
US8010189B2 (en) 2004-02-20 2011-08-30 Brainsgate Ltd. SPG stimulation for treating complications of subarachnoid hemorrhage
ES2625259T3 (en) 2006-08-29 2017-07-19 Oxford Biotherapeutics Ltd Identification of protein associated with hepatocellular carcinoma, glioblastoma and lung cancer
EP1918299A1 (en) * 2006-11-03 2008-05-07 Universite De Geneve Modulators of cell adhesion molecules and use thereof
WO2008142693A2 (en) * 2007-05-22 2008-11-27 Yeda Research And Development Co. Ltd. Regulation of myelination by nectin-like (necl) molecules
BRPI1009232B1 (en) 2009-03-05 2022-05-03 E.R. Squibb & Sons, Llc. Isolated monoclonal antibody or an antigen-binding portion thereof, or an antibody fragment, composition comprising them, nucleic acid molecule, hybridoma and methods for preparing an anti-cadm1 antibody
US9675796B2 (en) 2013-11-10 2017-06-13 Brainsgate Ltd. Implant and delivery system for neural stimulator
US10271907B2 (en) 2015-05-13 2019-04-30 Brainsgate Ltd. Implant and delivery system for neural stimulator

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999004263A1 (en) * 1997-07-17 1999-01-28 The John Hopkins University School Of Medicine Semaphorin receptor
WO2001029215A2 (en) * 1999-10-19 2001-04-26 Compugen Ltd. N-cam homolog and splice variants thereof
WO2002038744A2 (en) * 2000-10-18 2002-05-16 Incyte Genomics, Inc. Proteases

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999004263A1 (en) * 1997-07-17 1999-01-28 The John Hopkins University School Of Medicine Semaphorin receptor
WO2001029215A2 (en) * 1999-10-19 2001-04-26 Compugen Ltd. N-cam homolog and splice variants thereof
WO2002038744A2 (en) * 2000-10-18 2002-05-16 Incyte Genomics, Inc. Proteases

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
OSADA N ET AL: "Macaca fascicularis brain cDNA, clone:QccE-16296", EMBL, XP002173301 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9233245B2 (en) 2004-02-20 2016-01-12 Brainsgate Ltd. SPG stimulation
US8958881B2 (en) 2005-08-19 2015-02-17 Brainsgate Ltd. Neuroprotective electrical stimulation

Also Published As

Publication number Publication date
WO2002066643A2 (en) 2002-08-29

Similar Documents

Publication Publication Date Title
WO2002014368A8 (en) Proteins and nucleic acids encoding the same
WO2002006339A3 (en) Proteins and nucleic acids encoding same
WO2002055705A3 (en) Proteins and nucleic acids encoding same
WO2002064791A3 (en) Proteins and nucleic acids encoding same
WO2002050277A3 (en) Protein and nucleic acids encoding same
WO2002057453A3 (en) Polypetides and nucleic acids encoding same
WO2002068649A3 (en) Proteins and nucleic acids encoding same
WO2002057450A3 (en) Proteins and nucleic acids encoding same
WO2002081518A3 (en) Proteins, polynucleotides encoding them and methods of using the same
WO2002029058A3 (en) Human proteins, polynucleotides encoding them and methods of using the same
WO2001060990A3 (en) Sphingosine kinases
WO2001090155A3 (en) Novx proteins and nucleic acids encoding same. diagnostic and therapeutic uses
WO2002098917A3 (en) Human proteins and nucleic acids encoding same
WO2001081578A3 (en) Novel proteins and nucleic acids encoding same
WO2001029217A3 (en) Novel polypeptides and polynucleotides encoding same
WO2002068652A3 (en) Nov-x proteins and nucleic acids encoding same
WO2002016599A3 (en) Proteins and nucleic acids encoding same
WO2002055704A3 (en) Proteins, polynucleotides encoding them and methods of using the same
WO2002029038A3 (en) Novel proteins and nucleic acids encoding same and antibodies directed against these proteins
WO2002055702A3 (en) Human proteins, polynucleotides encoding them and methods of using the same
WO2002081510A3 (en) Proteins, polynucleotides encoding them and methods of using the same
WO2002010216A3 (en) Proteins and nucleic acids encoding same
WO2002000691A3 (en) Polynucleotides and polypeptides encoded thereby
WO2002066643A3 (en) Proteins, polynucleotides encoding them and methods of using the same
WO2002046229A3 (en) Novel proteins and nucleic acids encoding same

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP